By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Jury Holds CVS, Walgreen and Walmart Accountable For Role In Opioid Crisis
A federal jury has found CVS, Walmart, and Walgreens responsible for distributing millions of painkillers in two Ohio counties, which as a result fueled the opioid crisis there. The verdict could set the tone for cities and counties across the country that want to hold pharmacies accountable for their role in the opioid epidemic. Barak Lurie, partner and principal attorney at Lurie and Kramer, joined Cheddar to discuss why he thinks the verdict will be overruled.
Republicans Warming Up to Legalizing Weed
Natalie Fertig, Federal Cannabis Policy Reporter for Politico Pro, joined Cheddar to discuss the shift among republicans to support federally legalizing marijuana.
Bitcoin Sees Dip After Concerns of New COVID Variant
Bitcoin has officially entered bear market territory. The cryptocurrency is down 20% from an all-time high of nearly $69,000 dollars, which it hit earlier this month. Experts mark the new potentially vaccine-resistant coronavirus variant as the reason for the dip. Patrick McConlogue, CEO of Overlin, joins Cheddar News to discuss.
Stocks Close Lower On Convers Over New COVID-19 Variant
U.S. markets were open for an abbreviated session on the day after Thanksgiving, and the day saw a market meltdown. The Dow dropped more than 900 points for its worst day of the year. Matt Orton, Chief Market Strategist at Carillon Tower Advisers, joined Cheddar News' Closing Bell to discuss.
Load More